Poulsbo's wellness culture drives strong interest in GLP-1 treatments. Rybelsus® is the FDA-approved Oral tablet Semaglutide product manufactured by Novo Nordisk. Weight Method offers a separate program for Poulsbo residents: licensed Washington providers evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program starts at $199/month, with the provider evaluation, the medication, ongoing care, and home delivery to Poulsbo included.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Poulsbo is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Poulsbo, WA. Weight Method offers compounded semaglutide, prescribed by licensed providers, from $199/month with virtual consultations and direct-to-door shipping.
Semaglutide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Novo Nordisk developed Rybelsus® as the FDA-approved Oral tablet product, taken Once daily, approved in 2019. Weight Method is a separate program: licensed providers in Washington evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program for eligible Poulsbo, WA residents starts at $199/month.
In the suburbs of Poulsbo, getting to a weight loss specialist often means a drive to a medical center and a long wait for an appointment. Weight Method eliminates that obstacle: consult with a licensed Washington provider from your home, receive your compounded Semaglutide prescription (dispensed by a U.S.-licensed 503A pharmacy; compounded Semaglutide is not FDA-approved), and have it shipped directly at $199/month.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Washington and start Rybelsus from $199/month.
Get Started NowFree consultation. No commitment.